In Merrifield-based solid-phase peptide synthesis, BOC-L-hydroxyproline (CAS 13726-69-7, C10H17NO5, molar mass 231.25 g/mol) is introduced as a protected secondary amine onto aminomethyl polystyrene cross-linked with 1% divinylbenzene. The C4 hydroxyl remains unprotected during Boc-cycle assembly, which differs from Fmoc-SPPS in which the corresponding Fmoc-Hyp(tBu)-OH carries an acid-labile tert-butyl ether. Resin substitution levels of 0.2–0.8 mmol/g are obtained by caesium salt-mediated loading onto chloromethyl resin or by coupling to pre-formed PAM linkers. Automated peptide synthesizers with 20 mL or 50 mL jacketed reaction vessels and PTFE frits with 20 µm porosity are charged with pre-swelled resin; DCM swelling volumes are 4–6 mL/g, while DMF-contracted beds require agitation torque adjustments on vortex mixers. Activation is carried out with DIC/HOBt in DMF-DCM (1:1, v/v) at 0–5 °C for 30–60 min, followed by transfer to the resin and coupling at 20–25 °C for 1–4 h. The secondary nitrogen of hydroxyproline is sterically hindered; reaction completion is not assessed by the Kaiser test because it gives false negatives for secondary amines. Instead, the chloranil test is applied on resin aliquots, with a negative result indicated by no blue-green colouration. Manufacturing lines frequently perform double coupling for Hyp residues, especially when hydroxyproline is followed by valine or isoleucine, and batch records include coupling temperature, activation interval, and chloranil readout for every cycle.The dominant impurity mechanism in this application is O-acylation at the free C4 hydroxyl. Activated amino acyl species can react with the hydroxyl to form depsipeptide linkages, which remain stable through trifluoroacetic acid deprotection and co-elute with the target peptide on C18 reversed-phase analytical columns using acetonitrile gradients below 25%. The use of HOAt or 6-Cl-HOBt in combination with PyBOP lowers O-acylation when activation is performed at −10–0 °C for 15 min before coupling. In process development, the O-acyl impurity is quantitated by RP-HPLC with UV detection at 214 nm; for peptide APIs the acceptance limit is normally set below 0.5% in the crude peptide under ICH Q6B specification frameworks. Failure to control this impurity results in a second preparative chromatography pass on a C4 column with 300 Å pore size and 10–15 µm particles because C18 materials with 100 Å pores do not provide adequate mass-transfer resolution for aggregated collagen fragments.

Coupling system	Base	Reaction temperature	O-acylation tendency	Application boundary
DIC/HOBt	DIEA	0–5 °C	Moderate at 20 °C	Solution-phase and resin esterification
HBTU/DIEA	DIEA	20–25 °C	Elevated	Fast coupling of primary amines; avoid for free C4 OH
PyBOP/HOAt	DIEA	−10–0 °C	Low	Hindered secondary amine coupling
COMU/Oxyma	DIEA	0–15 °C	Low	Peptide API cGMP sequences

The final cleavage stage for hydroxyproline-containing peptides on PAM or MBHA resin uses anhydrous HF at 0 °C for 60–90 min with p-thiocresol and dimethyl sulfide as scavengers. The free hydroxyl group of Hyp is not a major alkylation site under these conditions, but insufficient thiol scavenger concentration leads to benzyl cation re-attachment at aromatic and oxygen nucleophiles. Crude precipitation in cold diethyl ether at −20 °C followed by centrifugation in solvent-resistant vessels yields a crude purity range of 60–85% for collagen-like (Gly-Pro-Hyp)n repeats. Residual trifluoroacetate from Boc removal is determined by ion chromatography under USP<621> and controlled to below 0.1% w/w in final peptide drug substances. Lyophilised peptide powders are released only after Karl Fischer titration indicates water content below 5%. Commercial GMP peptide campaigns operate under ICH Q7 with batch records that include resin substitution, activation temperatures, chloranil results, HF cleavage time, and preparative chromatographic recovery; environmental monitoring follows ISO 14644-1 Class 8 or better for open-charge operations.

What Synthetic Utility Emerges When Boc-Hyp Is Oxidised or Substituted at the C4 Position?

Beyond peptide assembly, BOC-L-Hydroxyproline functions as a chiral pool starting material for 4-substituted pyrrolidine building blocks used in medicinal chemistry. The C4 hydroxyl is converted to a leaving group by treatment with p-toluenesulfonyl chloride in pyridine at 0–5 °C; the resulting 4-O-tosyl intermediate is extracted into methyl tert-butyl ether and washed with aqueous citric acid to remove pyridine. Nucleophilic displacement with sodium azide in anhydrous DMF at 55–65 °C for 16–24 h produces 4-azido-L-proline with inversion at C4. The Boc group remains intact when the aqueous workup is held above pH 4; acidic quench below this threshold removes the carbamate and generates secondary amine salts that partition into the aqueous phase. Chiral purity is assessed by Marfey’s reagent derivatisation followed by C18 HPLC, with the undesired enantiomer controlled below 1.0%. The resulting azide is reduced with triphenylphosphine in THF-water or with hydrogen over Lindlar catalyst to yield 4-amino-L-proline derivatives.Oxidation of the C4 alcohol with Dess-Martin periodinane or Swern conditions gives N-Boc-4-oxo-L-proline, which is used in reductive amination and Grignard addition reactions. The ketone is sensitive to enolisation and racemisation at C5; reaction temperatures are held at −70 to −60 °C for oxalyl chloride/Swern activation and at −40 to −30 °C for nucleophile addition. On pilot scale, the use of Dess-Martin reagent in DCM at 0–20 °C avoids cryogenic equipment and improves heat transfer in glass-lined reactors, although iodinate by-product removal by sodium thiosulfate is required before workup. These transformations generate constrained pyrrolidine scaffolds for integrin receptor ligands and chiral organocatalyst intermediates, and the batch process equipment in medicinal chemistry kilo-labs typically includes coil reactors for diazo-free azide substitution and microfiltered solvent delivery to meet ICH Q11 development requirements.Dipalmitoyl hydroxyproline, a lipophilic amino acid derivative used in anti-wrinkle cosmetic preparations, is produced from BOC-L-Hydroxyproline by acidolytic removal of the tert-butyloxycarbonyl group followed by Schotten-Baumann acylation. The deprotected hydroxyproline is neutralised to pH 8–9 in aqueous/organic medium and treated with palmitoyl chloride in a jacketed reactor at 10–20 °C; the C4 hydroxyl is acylated in the same operation, yielding the N,O-dipalmitoyl derivative. Reaction mass transfer at production scale is controlled with a turbine impeller speed of 150–250 rpm, and the exothermic acylation is moderated by metered addition of the acid chloride over 2–3 h. The crude product is precipitated from cold methanol at 0 °C, washed with water to remove chloride, and dried under vacuum at 40 °C until loss on drying is below 0.5%. The finished material is incorporated into cosmetic emulsions under safety assessment provisions of EC 1223/2009 Annex III and manufactured under ISO 22716 GMP. In skin-care formulations, the dipalmitoyl hydroxyproline ester is declared as a skin-conditioning agent; its melting interval is assessed by differential scanning calorimetry at a heating rate of 10 K/min, and residual palmitic acid is controlled by acid value titrations according to ISO 660:2020. Incompatibility arises with strongly cationic thickening polymers and with formulations below pH 4, where ester hydrolysis can release palmitic acid over the shelf-life period.

When N-Carboxyanhydride Polymerisation Replaces Solid-Phase Assembly for Hyp-Rich Polymers

BOC-L-Hydroxyproline serves as an intermediate in the preparation of hydroxyproline N-carboxyanhydride monomers for ring-opening polymerisation. The Boc group is removed with hydrogen chloride in dioxane at 0–10 °C, and the resulting hydrochloride is reacted with triphosgene in anhydrous THF under a nitrogen sweep at 35–45 °C. The NCA monomer is crystallised from ethyl acetate/hexane at −20 °C and stored in a desiccator because residual moisture above 0.05% as measured by Karl Fischer triggers premature polymerisation. Polymerisation is initiated with n-hexylamine or methoxy-PEG amine in a glovebox with oxygen below 10 ppm; the monomer-to-initator ratio is varied from 40:1 to 200:1 to target degree of polymerisation. Conversion is followed by FTIR disappearance of the anhydride carbonyl at 1790 cm⁻¹ and molecular weight is determined by gel permeation chromatography using polystyrene calibration with a refractive index detector. Poly(hydroxyproline) and block copolymers with poly(ethylene glycol) are obtained with molar mass dispersities in the range 1.2–1.4.The resulting hydroxyproline-containing polymers are evaluated as surface-grafted biointerfaces for cell adhesion and as collagen-mimetic coatings on titanium implants. Coatings are applied by dip-coating from 0.1–1.0% polymer solutions in trifluoroethanol at 25 °C; the grafts are stabilised by annealing at 60 °C for 4 h. Surface thickness is measured by spectroscopic ellipsometry and should remain 5–20 nm for subsequent in vitro adhesion studies. Biocompatibility evaluation under ISO 10993-5 uses elution or direct contact with L929 fibroblasts; the operational boundary is set by residual organic solvents from the polymerisation, which must be below ICH Q3C limits for pharmaceutical device components. Because unprotected hydroxyl groups can undergo acid-catalysed elimination to unsaturated proline at high temperature, thermal processing above 150 °C is avoided.

Organocatalytic Aldol Reactions After Acidolytic Deprotection

After selective removal of the Boc group with trifluoroacetic acid in DCM at 0 °C, the secondary amine of L-hydroxyproline becomes available for enamine catalysis. The deprotection mixture is neutralised with aqueous sodium bicarbonate to pH 7–8, and the zwitterionic catalyst is extracted into methanol or isopropanol. Typical asymmetric aldol reactions between acetone and 4-nitrobenzaldehyde are conducted with 10 mol% catalyst loading at 25 °C for 24–48 h; published data for this specific configuration report enantiomeric excess in the range 80–95% and yields between 50–80% after column chromatography. The C4 hydroxyl group improves catalyst solubility in aqueous ketone media and also participates in transition-state hydrogen bonding. Process development at kilogram scale is limited by catalyst recovery from the aqueous phase; continuous extraction with methyl ethyl ketone in a countercurrent column is used to recover the catalyst, but the zwitterionic charge distribution makes partition coefficient log D7.4 a controlling variable. Chiral HPLC with a normal-phase cellulose-derived column is used to quantify the enantiomeric excess; the mobile phase is hexane/isopropanol (80:20, v/v) at 1.0 mL/min. Incompatibility exists with strongly acidic workup or with Lewis acidic metal impurities from upstream synthesis, which poison the enamine cycle.

PEGylation and Fluorophore Conjugation Through a Free C4 Hydroxyl

Peptide intermediates assembled from BOC-L-Hydroxyproline leave a C4 hydroxyl that can be selectively derivatised after chain assembly in solution phase. This site is used for the introduction of methoxy-poly(ethylene glycol) ester grafts, fluorescent reporters, and biotin. A typical PEGylation uses mPEG-succinimidyl carbonate with DMAP in anhydrous DMF at 20–25 °C for 12–18 h; the conjugation degree is monitored by size-exclusion chromatography and by ¹H NMR integration of the mPEG methylene signal against the hydroxyproline C4 methine signal. Unreacted PEG reagent is removed by diafiltration with a 1 kDa regenerated cellulose membrane. For fluorophore attachment, 6-carboxytetramethylrhodamine is pre-activated with EDC/NHS in DMF at 0 °C, then added to the hydroxyproline-containing peptide at pH 8.0 in bicarbonate buffer. Conjugates are purified by preparative reversed-phase HPLC on C4 columns with 300 Å pores; retention times are affected by the amphiphilic character of the PEGylated peptides.The final products are used as in vitro collagenase substrate probes and in tissue imaging studies. Because these conjugates may enter biological testing, residual ester hydrolysis is a defined boundary: the C4 ester is cleaved by esterases at pH 7.4 and 37 °C with variable half-life depending on the fatty acid or PEG chain length. For diagnostic applications, residual organic solvents are controlled under ICH Q3C, and endotoxin levels for in vivo imaging batches are tested by compendial methods such as USP<85>. The free hydroxyl route is preferred over amine conjugation when the N-terminus of the peptide must remain available for receptor binding; in this context, the BOC protecting strategy has already removed the N-terminal carbamate before final conjugation.